---
title: "gmx_MMPBSA expands end-state binding free energy tools for GROMACS and AMBER"
id: "biorxiv-4-expanding-gmx-mmpbsa-capabilities-for-end-state-binding-free-energy"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-4-expanding-gmx-mmpbsa-capabilities-for-end-state-binding-free-energy"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1?rss=1"
published_at: "2026-10-24T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# gmx_MMPBSA expands end-state binding free energy tools for GROMACS and AMBER
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-4-expanding-gmx-mmpbsa-capabilities-for-end-state-binding-free-energy
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1?rss=1)
- **Published At:** 2026-10-24T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors presented expanded capabilities for the end-state binding free energy package **gmx_MMPBSA** to simplify setup and broaden calculation options. - New solvation and electrostatics options were added: the **GBNSR6** model and a nonlinear **PB** model, allowing alternative implicit solvent treatments. - Entropy estimation received a new option: second-order cumulant (C2) entropy calculation was included as an available estimator. - Structural treatment now supports explicit structural waters; users can include these in binding calculations when warranted by the system. - Mutation scanning was extended to handle multiple alanine and glycine substitutions in a single analysis workflow. - The team released **amber_MMPBSA**, an entry point accepting native **AMBER** input files and bridging AMBER users into the gmx_MMPBSA ecosystem. - Data analysis tools were modernized: a redesigned graphical analyzer, **gmx_MMPBSA_ana**, plus a refreshed Python API to handle large datasets and cross-system comparisons. - The authors illustrated features across diverse complexes — protein–protein, protein–RNA, protein–small molecule, and DNA–small molecule — and reported that calculated binding energies vary with methodological choices. - The source code and resources are publicly available at the project GitHub repository (https://github.com/Valdes-Tresanco-MS/gmx_MMPBSA). - The preprint has not undergone peer review; the article did not report external benchmarking statistics, specific computational parameters, or regulatory milestones.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Expanding gmx_MMPBSA capabilities for end-state binding free energy calculations with GROMACS and AMBER [ View ORCID Profile](http://orcid.org/0000-0002-9625-6988)Mario E. Valdés-Tresanco, [ View ORCID Profile](http://orcid.org/0000-0002-1291-1587)Mario S. Valdés-Tresanco, [ View ORCID Profile](http://orcid.org/0000-0002-0172-5041)Glenda Romero-Hernández, Pedro A. Valiente, [ View ORCID Profile](http://orcid.org/0000-0002-2309-4826)Ernesto Moreno doi: https://doi.org/10.64898/2026.10.24.761505 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Mario E. Valdés-Tresanco 1 Department of Biological Sciences, University of Calgary, Calgary, Alberta, T2N 1N4, Canada; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mario%2BE.%2BVald%C3%A9s-Tresanco%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Vald%C3%A9s-Tresanco%20ME&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMario%2BE.%2BVald%25C3%25A9s-Tresanco%2B) * [ORCID record for Mario E. Valdés-Tresanco](http://orcid.org/0000-0002-9625-6988 "Open in new tab") * For correspondence: marioe911116@gmail.com Mario S. Valdés-Tresanco 2 Institute of Basic Sciences, Faculty of Engineering, University of Medellin, Medellin, Colombia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mario%2BS.%2BVald%C3%A9s-Tresanco%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Vald%C3%A9s-Tresanco%20MS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMario%2BS.%2BVald%25C3%25A9s-Tresanco%2B) * [ORCID record for Mario S. Valdés-Tresanco](http://orcid.org/0000-0002-1291-1587 "Open in new tab") Glenda Romero-Hernández 1 Department of Biological Sciences, University of Calgary, Calgary, Alberta, T2N 1N4, Canada; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Glenda%2BRomero-Hern%C3%A1ndez%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Romero-Hern%C3%A1ndez%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AGlenda%2BRomero-Hern%25C3%25A1ndez%2B) * [ORCID record for Glenda Romero-Hernández](http://orcid.org/0000-0002-0172-5041 "Open in new tab") Pedro A. Valiente 3 Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada. * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Pedro%2BA.%2BValiente%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Valiente%20PA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3APedro%2BA.%2BValiente%2B) Ernesto Moreno 2 Institute of Basic Sciences, Faculty of Engineering, University of Medellin, Medellin, Colombia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ernesto%2BMoreno%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Moreno%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AErnesto%2BMoreno%2B) * [ORCID record for Ernesto Moreno](http://orcid.org/0000-0002-2309-4826 "Open in new tab") * [Abstract](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5901219/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5901219/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5901219/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5901219/1) * [Data/Code](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1.external-links)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_data_code/node:5901219/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5901219/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract gmx_MMPBSA is an end-to-end tool for performing end-state binding free energy calculations. Here, we present advances in the gmx_MMPBSA suite that simplify preparation, expand the calculation options, and improve the analysis of results. The new features include the GBNSR6 and nonlinear PB models, second-order cumulant (C2) entropy estimation, inclusion of explicit structural waters, and multiple alanine/glycine mutations. We also introduce amber_MMPBSA, a new entry point that accepts native AMBER input files and extends the calculation and analysis capabilities of gmx_MMPBSA to AMBER users. The redesigned graphical analyzer, gmx_MMPBSA_ana, and modernized Python API facilitate exploration of large datasets and comparisons across multiple systems. We illustrate the new gmx_MMPBSA capabilities using a diverse set of biomolecular complexes (protein-protein, protein-RNA, protein-small molecule, DNA-small molecule) and show how the calculated binding energies vary across systems depending on the methodological choices. The source code is available at https://github.com/Valdes-Tresanco-MS/gmx_MMPBSA. ### Competing Interest Statement The authors have declared no competing interest. ## Footnotes * Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.10.20.760373v1 "Multi-scale microenvironment covariance for unsupervised spatial domain identification")[Next ](https://www.biorxiv.org/content/10.64898/2026.10.23.761443v1 "Viral host assignment across the tree of life with VHAMSTeR") Posted October 24, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/10/24/2026.10.24.761505.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.10.24.761505v1.supplementary-material) [ Data/Code](https://www.biorxiv.org/content/early/2026/10/24/2026.10.24.761505.external-links) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Expanding gmx_MMPBSA capabilities for end-state binding free energy calculations with GROMACS and AMBER Mario E. Valdés-Tresanco, Mario S. Valdés-Tresanco, Glenda Romero-Hernández, Pedro A. Valiente, Ernesto Moreno bioRxiv 2026.10.24.761505; doi: https://doi.org/10.64898/2026.10.24.761505 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.10.24.761505v1%26text%3DExpanding%2520gmx_MMPBSA%2520capabilities%2520for%2520end-state%2520binding%2520free%2520energy%2520calculations%2520with%2520GROMACS%2520and%2520AMBER "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.10.24.761505v1%26t%3DExpanding%2520gmx_MMPBSA%2520capabilities%2520for%2520end-state%2520binding%2520free%2520energy%2520calculations%2520with%2520GROMACS%2520and%2520AMBER "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.10.24.761505v1%26title%3DExpanding%2520gmx_MMPBSA%2520capabilities%2520for%2520end-state%2520binding%2520free%2520energy%2520calculations%2520with%2520GROMACS%2520and%2520AMBER%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.10.24.761505v1%26title%3DExpanding%2520gmx_MMPBSA%2520capabilities%2520for%2520end-state%2520binding%2520free%2520energy%2520calculations%2520with%2520GROMACS%2520and%2520AMBER "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.10.24.761505) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.10.24.761505v1&count=horizontal&via=&text=Expanding%20gmx_MMPBSA%20capabilities%20for%20end-state%20binding%20free%20energy%20calculations%20with%20GROMACS%20and%20AMBER&counturl=www.biorxiv.org/content/10.64898/2026.10.24.761505v1 "Tweet This") ## Subject Area * [Bioinformatics ](https://www.biorxiv.org/collection/bioinformatics) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering
## Related Clinical Research

- [PINN-iPRC: Inferring infinitesimal phase response curves from finite-pulse circadian data](https://medichelpline.com/clinical-feed/biorxiv-3-a-physics-informed-neural-network-framework-for-inferring-infinitesimal-phase.md)
- [Agent K: Automated LLM-Orchestrated Pipeline for Mapping Genes to Biosynthetic Pathways](https://medichelpline.com/clinical-feed/biorxiv-4-agent-k-an-agent-orchestrated-pipeline-for-mapping-genes-to-biosynthetic.md)
- [Mitochondrial dysfunction in neurology: biomarkers for diagnosis, stratification and monitoring](https://medichelpline.com/clinical-feed/nature-reviews-neurology-0-mitochondrial-dysfunction-in-neurology-biomarkers-and-clinical-implications.md)
- [Retraction Notice: Syzygium heyneanum study on paraquat-induced Parkinsonian model withdrawn by PL](https://medichelpline.com/clinical-feed/plos-one-2-retraction-biochemical-properties-and-biological-potential-of-syzygium.md)
- [PLOS One Retracts Cissus tuberosa Parkinson’s Disease Study Over Data and Image Concerns](https://medichelpline.com/clinical-feed/plos-one-1-retraction-anti-neuroinflammatory-and-neuroprotective-potential-of-cissus.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.